anti-Ret Proto-Oncogene (RET) Antikörper

Bezeichnung:: anti-Ret Proto-Oncogene Antikörper (RET)

Auf www.antikoerper-online.de finden Sie aktuell 391 Ret Proto-Oncogene (RET) Antikörper von 23 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen Ret Proto-Oncogene Proteine (38) und Ret Proto-Oncogene Kits (16) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 465 Ret Proto-Oncogene Produkte verfügbar.

Synonyme:: c-Ret, CDHF12, CDHR16, cret, etID315074.13, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET, ret-A, RET-ELE1, ret1, RET9, RET51, wu:fd13h01, X-ret, xret

Alle Antikörper anzeigen	Gen	GeneID	UniProt
	RET	5979	P07949
	RET	19713	P35546
	RET	24716
Alle Spezies anzeigen Weitere Synonyme anzeigen

Meistgesuchte Reaktivitäten zu anti-Ret Proto-Oncogene (RET) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Human Ret Proto-Oncogene Antikörper:

anti-Mouse (Murine) Ret Proto-Oncogene Antikörper:

anti-Rat (Rattus) Ret Proto-Oncogene Antikörper:

Alle verfügbaren anti-Ret Proto-Oncogene Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Verknüpfte Pathways mit anti-Ret Proto-Oncogene Antikörper

Weitere Produktkategorien zu Ret Proto-Oncogene Antikörper

Am meisten referenzierte anti-Ret Proto-Oncogene Antikörper

Human Polyclonal Ret Proto-Oncogene Primary Antibody für WB - ABIN1882126 : Siqueira, Romitti, da Rocha, Ceolin, Meotti, Estivalet, Puñales, Maia: The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma. in Endocrine-related cancer 2010 (PubMed)
Show all 4 Pubmed References
Human Monoclonal Ret Proto-Oncogene Primary Antibody für ELISA, WB - ABIN1724678 : Young, Anderson, Anderson: Guidance cues involved in the development of the peripheral autonomic nervous system. in Autonomic neuroscience : basic & clinical 2004 (PubMed)
Show all 2 Pubmed References
Human Monoclonal Ret Proto-Oncogene Primary Antibody für ELISA, WB - ABIN1724684 : Myers, Mulligan: The RET receptor is linked to stress response pathways. in Cancer research 2004 (PubMed)
Show all 2 Pubmed References
Human Polyclonal Ret Proto-Oncogene Primary Antibody für ICC, IF - ABIN4350058 : Luo, Tsuchiya, Il Park, Fausel, Kanngurn, Welcsh, Dzieciatkowski, Wang, Grady: RET is a potential tumor suppressor gene in colorectal cancer. in Oncogene 2013 (PubMed)
Show all 2 Pubmed References
Human Monoclonal Ret Proto-Oncogene Primary Antibody für CyTOF, FACS - ABIN4900140 : Fonseca-Pereira, Arroz-Madeira, Rodrigues-Campos, Barbosa, Domingues, Bento, Almeida, Ribeiro, Potocnik, Enomoto, Veiga-Fernandes: The neurotrophic factor receptor RET drives haematopoietic stem cell survival and function. in Nature 2014 (PubMed)
Show all 2 Pubmed References
Human Monoclonal Ret Proto-Oncogene Primary Antibody für CyTOF, FACS - ABIN4900141 : Kubota, Wu, Goodyear, Avarbock, Brinster: Glial cell line-derived neurotrophic factor and endothelial cells promote self-renewal of rabbit germ cells with spermatogonial stem cell properties. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2011 (PubMed)
Show all 2 Pubmed References
Human Monoclonal Ret Proto-Oncogene Primary Antibody für IHC (p), IHC - ABIN269684 : Barrenschee, Böttner, Hellwig, Harde, Egberts, Becker, Wedel: Site-specific gene expression and localization of growth factor ligand receptors RET, GFRα1 and GFRα2 in human adult colon. in Cell and tissue research 2013 (PubMed)
Human Polyclonal Ret Proto-Oncogene Primary Antibody für IHC (p), WB - ABIN392038 : Takaki, Nakayama, Misawa, Nakagawa, Kuniyasu: In vitro formation of enteric neural network structure in a gut-like organ differentiated from mouse embryonic stem cells. in Stem cells (Dayton, Ohio) 2006 (PubMed)
Human Polyclonal Ret Proto-Oncogene Primary Antibody für WB - ABIN392039 : de Martimprey, Bertrand, Fusco, Santoro, Couvreur, Vauthier, Malvy: siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma. in Nucleic acids research 2008 (PubMed)

Weitere Antikörper gegen Ret Proto-Oncogene Interaktionspartner

Zebrafish Ret Proto-Oncogene (RET) Interaktionspartner

These data provide the first evidence for a physiologic role of these isoforms in RET pathway function.
Significantly, we show that introduction of mapk10 (zeige MAPK10 Antikörper) mutations into ret heterozygotes enhanced the ENS deficit, supporting MAPK10 (zeige MAPK10 Antikörper) as a Hirschsprung disease (HSCR (zeige EDNRB Antikörper)) susceptibility locus. Our studies demonstrate that ret heterozygous zebrafish is a sensitized model, with many significant advantages over existing murine models, to explore the pathophysiology and complex genetics of HSCR (zeige EDNRB Antikörper).
RET expression is investigated within the brain of zebrafish; both RET protein and mRNA are observed.
In animals lacking Ret or Gfra3 (zeige GFRA3 Antikörper) function, myogenic gene expression is reduced in forming opercular muscles, but not in non-opercular muscles derived from the same muscle anlagen.
evaluation of noncoding sequences at the zebrafish ret locus conserved among teleosts, and at the human RET locus, conserved among mammals
genes beyond RET may be implicated in the genesis of sporadic cases of HD

Human Ret Proto-Oncogene (RET) Interaktionspartner

RET p.C634F mutation is associated with Multiple Endocrine Neoplasia Type 2A with Cutaneous Lichen Amyloidosis.
These data support the inclusion of patients bearing RET alterations in ongoing and future molecularly enriched clinical trials to explore RXDX-105 efficacy across a variety of tumor types.
These results implicate EGFR (zeige EGFR Antikörper) as a key regulator of RET activation in A+AD and suggest that EGFR (zeige EGFR Antikörper) inhibitors may be therapeutic in patients with A+AD tumors even in the absence of an EGFR (zeige EGFR Antikörper) or RET mutation.
In a cohort of MEN 2 families, the distribution of RET mutations in Denmark appears to differ from that of other populations. Mutations in codon 611 were the most prevalent, followed by more frequently reported mutations. This might be due to a possible founder effect for the p.C611Y mutation.
RET inhibitors could both impair primary tumor growth and tumor dissemination, thereby providing a potential therapeutic advantage when used in combination with aromatase (zeige CYP19A1 Antikörper) inhibitors in postmenopausal ER+ breast cancers.
exposure of medullary thyroid cancer cells to a tri (zeige VANGL2 Antikörper)-substituted naphthalene diimide resulted in a significant antiproliferative activity paralleled by inhibition of RET expression
Our data show that RET expression promotes a more mesenchymal phenotype with reduced cell-cell adhesion and increased invasiveness in papillary thyroid carcinoma cell models, but is more important for tumour cell survival, proliferation and anoikis resistance in medullary thyroid carcinoma models. Our data suggest that the RET51 isoform plays a more prominent role in mediating these processes compared to RET9.
From this case series, the largest such experience to date, it is concluded that the RET(K666N) variant is likely pathogenic and associated with low penetrance of medullary thyroid carcinoma.
Multilayer OMIC data analysis uncovered methylation hallmarks in genetically defined Medullary thyroid carcinoma (MTC (zeige MT1A Antikörper)) and revealed JAK (zeige JAK3 Antikörper)/Stat (zeige STAT1 Antikörper) signaling effector STAT3 (zeige STAT3 Antikörper) as a potential therapeutic target for the treatment of RET(M918T) MTCs
DNA mutational analysis of RET germline mutations associated with medullary thyroid carcinoma in a Druze family.

Mouse (Murine) Ret Proto-Oncogene (RET) Interaktionspartner

Compromised Survival of Cerebellar Molecular Layer Interneurons Lacking GDNF Receptors GFRalpha1 (zeige GFRA1 Antikörper) or RET Impairs Normal Cerebellar Motor Learning
Data show that NEDL2 regulates GDNF/Ret/Akt pathway depends on its Nedd8 ligase activity rather than ubiquitin ligase activity.
The cardiac GFRA2 (zeige GFRA2 Antikörper) signaling pathway is distinct from the canonical pathway dependent on the RET tyrosine kinase (zeige TYRO3 Antikörper).
Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model.
Mechanistically, Ret is engaged in a positive feedback loop with Wnt/Wingless signalling, modulated by Src and Fak kinases.
Authors did not find evidence for genetic interaction between Ret and Sema3d (zeige SEMA3D Antikörper) affecting survival, presence of myenteric plexus or intestine transcriptome.
findings uncover a novel spinal circuit that mediates crosstalk between touch and pain pathways and suggest that some early RET positive Dorsal Horn neurons could function as pain "gating" neurons.
Using an organ culture system for prostate development and Ret mutant mice, we demonstrate that RET-mediated GDNF signaling in UGS increases proliferation of mesenchyme cells and suppresses androgen-induced proliferation and differentiation of prostate epithelial cells, inhibiting prostate development.
we described a RET-ER81 (zeige ETV1 Antikörper)-Neuregulin1 signaling pathway in neurons innervating Pacinian corpuscle somatosensory end organs, which is essential for communication between the innervating axon and the end organ
These data provide the first evidence for a physiologic role of these isoforms in RET pathway function.

Ret Proto-Oncogene (RET) Antigen-Profil

Beschreibung des Gens

This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. Mutations in this gene are associated with the disorders multiple endocrine neoplasia, type IIA, multiple endocrine neoplasia, type IIB, Hirschsprung disease, and medullary thyroid carcinoma. Two transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their biological validity has not been confirmed.

Alternative names and synonyms associated with Ret Proto-Oncogene (RET)

ret proto-oncogene receptor tyrosine kinase (ret) Antikörper
ret proto-oncogene S homeolog (ret.S) Antikörper
ret proto-oncogene (RET) Antikörper
ret proto-oncogene (ret) Antikörper
ret proto-oncogene (Ret) Antikörper

c-Ret Antikörper
CDHF12 Antikörper
CDHR16 Antikörper
cret Antikörper
etID315074.13 Antikörper
HSCR1 Antikörper
MEN2A Antikörper
MEN2B Antikörper
MTC1 Antikörper
PTC Antikörper
RET Antikörper
ret-A Antikörper
RET-ELE1 Antikörper
ret1 Antikörper
RET9 Antikörper
RET51 Antikörper
wu:fd13h01 Antikörper
X-ret Antikörper
xret Antikörper

Bezeichner auf Proteinebene für RET

proto-oncogene tyrosine-protein kinase receptor Ret , receptor tyrosine kinase , ret proto-oncogene , tryptase , proto-oncogene tyrosine-protein kinase receptor Ret-like , RET transforming sequence , cadherin family member 12 , cadherin-related family member 16 , hydroxyaryl-protein kinase , proto-oncogene c-Ret , ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease) , Ret gene for receptor tyrosin , Ret proto-oncogene (multiple endocrine neoplasia MEN2A MEN2B and medullary thyroid carcinoma 1 Hirschsprung disease) , ret tyrosine kinase

GENE ID	SPEZIES
30512	Danio rerio
373625	Xenopus laevis
449594	Pan troglodytes
703466	Macaca mulatta
100033966	Equus caballus
100403596	Callithrix jacchus
100442682	Pongo abelii
100467317	Ailuropoda melanoleuca
100495902	Xenopus (Silurana) tropicalis
100602103	Nomascus leucogenys
5979	Homo sapiens
19713	Mus musculus
24716	Rattus norvegicus
403494	Canis lupus familiaris
396107	Gallus gallus
515924	Bos taurus
100340710	Oryctolagus cuniculus
100733392	Cavia porcellus

Ausgewählte Anbieter für anti-Ret Proto-Oncogene (RET) Antikörper

Haben Sie etwas anderes gesucht?

Telefon:	+1 877 302 8632
Fax:	+1 888 205 9894 (Toll-free)
E-Mail:	orders@antikoerper-online.de